New drug tested to fight dangerous fatty liver disease
Disease control
Completed
This study tested an investigational drug called BOS-580 (Efimosfermin) in 231 obese adults who had or were at risk for a serious fatty liver disease called NASH. The main goal was to check the drug's safety and how it behaved in the body. Some participants received the drug and …
Phase: PHASE2 • Sponsor: Boston Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC